Theranostic nanoparticles engineered for clinic and pharmaceutics

Area of Science:

• Nanomedicine and Nanotechnology
• Biomaterials Science
• Translational Medicine

Background:

• Nanoscale materials offer unique properties for interacting with biological systems, enabling novel diagnostic and therapeutic applications.
• Nanoparticles can be engineered for enhanced drug delivery, gene transfection, medical imaging, and early disease detection.
• The integration of diagnostic and therapeutic agents into single theranostic nanoparticles presents significant potential for personalized medicine.

Purpose of the Study:

• To describe the development of theranostic nanomaterials with low toxicity.
• To illustrate the potential of these novel nanomedicines in translational research.
• To highlight the importance of considering nanomaterial properties for minimizing toxicity in clinical applications.

Main Methods:

• Fabrication and evaluation of nanomaterials, including cationic amphiphilic polymers and metallofullerenes.
• Assessment of nanoparticle properties such as surface modification, bioactive cores, and integration of drugs and imaging agents.
• Investigation of biological responses to nanomaterials, considering factors like exposure levels, distribution, and subject age.

Main Results:

• Engineered nanoparticles exhibit advantageous properties including enhanced permeation and retention, targeted drug delivery, and efficient gene transfection.
• Novel theranostic nanomaterials demonstrate high efficiency and low toxicity in preclinical models for gene therapy and chemotherapy.
• Biological response to nanomaterials is influenced by exposure, accumulation, distribution, and subject age, necessitating careful consideration during development.

Conclusions:

• Theranostic nanomaterials hold promise as advanced nanomedicines for simultaneous diagnosis and therapy.
• Minimizing nanoparticle toxicity through careful engineering and consideration of biological interactions is crucial for clinical translation.
• Further research into the development and application of low-toxicity theranostic nanomaterials is essential for addressing intractable health challenges.